Key regions: South Korea, United States, Canada, United Kingdom, Australia
The Wound Care (Pharmacies) market in G7 is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.
Customer preferences: Customers in the G7 countries are increasingly seeking convenient and accessible healthcare solutions, which has led to a rise in demand for wound care products in pharmacies. Patients prefer to purchase wound care products from pharmacies due to the convenience of location and the availability of expert advice from pharmacists. Additionally, customers are becoming more conscious about their health and are actively seeking products that promote faster healing and minimize scarring. This has led to a growing demand for advanced wound care products in pharmacies.
Trends in the market: One of the key trends in the Wound Care (Pharmacies) market in G7 is the increasing adoption of advanced wound care products. These products offer superior healing properties and are designed to accelerate the wound healing process. Customers are willing to pay a premium for these advanced products as they provide better outcomes and minimize the risk of complications. Another trend observed in the market is the growing popularity of natural and organic wound care products. Customers are becoming more conscious about the ingredients used in wound care products and prefer natural alternatives that are gentle on the skin. This trend is driven by the rising awareness of the potential side effects of synthetic ingredients.
Local special circumstances: Each G7 country has its own unique set of circumstances that influence the development of the Wound Care (Pharmacies) market. For example, in the United States, the high prevalence of chronic wounds, such as diabetic foot ulcers, has fueled the demand for specialized wound care products. In Japan, the aging population has contributed to the growth of the market as older individuals are more prone to developing chronic wounds. In Germany, the strong pharmaceutical industry and the presence of well-established pharmacy chains have contributed to the growth of the market.
Underlying macroeconomic factors: The growth of the Wound Care (Pharmacies) market in G7 is also influenced by underlying macroeconomic factors. The increasing healthcare expenditure in these countries has led to improved access to healthcare services, including wound care products. Additionally, the rising disposable income of consumers has made them more willing to spend on premium wound care products. The growing emphasis on healthcare and wellness in these countries has also contributed to the growth of the market as individuals are becoming more proactive in managing their health. In conclusion, the Wound Care (Pharmacies) market in G7 is experiencing significant growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The increasing demand for convenient and accessible healthcare solutions, the adoption of advanced wound care products, and the preference for natural and organic alternatives are driving the growth of the market. The unique circumstances of each G7 country, such as the prevalence of chronic wounds and the aging population, further contribute to the development of the market. Additionally, the increasing healthcare expenditure, rising disposable income, and growing emphasis on healthcare and wellness are supporting the growth of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
